Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
That project, which the Food and Drug Administration (FDA) has greenlit, exemplifies a renaissance of research investigating the psychotherapeutic potential of a drug that has been federally prohibited since 1968.
- Simplified Text
-
FDA approved project shows renewed research into psilocybin.
- Confidence Score
- 0.800
- UUID
- 0f6ba0a7-8b8b-4a93-865a-4f506a3ffddf
- Vector Index
- ✗ No vector
- Created
- December 6, 2025 at 12:38 AM (4 months ago)
- Last Updated
- December 6, 2025 at 12:38 AM (4 months ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
18
claims
🔥
5 months ago
https://reason.com/2025/11/12/the-perils-of-viewing-psilocybin-strictly-as-a-psychiatric-medication
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.